Clinical Trial Update: Phase II Study of Single Agent Lenvatinib [Phase 2]

View source ↗

Summary

This clinical trial update reports an ongoing Phase II study of single-agent lenvatinib in breast cancer, with the current status undisclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• LENVIMA (lenvatinib)

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN